TherapeuticsMD (TXMD) Receivables - Other (2023 - 2025)
TherapeuticsMD (TXMD) has disclosed Receivables - Other for 7 consecutive years, with $3.7 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Other rose 10.29% year-over-year to $3.7 million, compared with a TTM value of $3.7 million through Sep 2025, up 10.29%, and an annual FY2024 reading of $3.6 million, down 83.49% over the prior year.
- Receivables - Other was $3.7 million for Q3 2025 at TherapeuticsMD, down from $3.7 million in the prior quarter.
- Across five years, Receivables - Other topped out at $21.6 million in Q4 2023 and bottomed at $2.9 million in Q2 2024.
- Average Receivables - Other over 3 years is $5.6 million, with a median of $3.4 million recorded in 2024.
- The sharpest move saw Receivables - Other tumbled 83.49% in 2024, then rose 28.71% in 2025.
- Year by year, Receivables - Other stood at $21.6 million in 2023, then crashed by 83.49% to $3.6 million in 2024, then grew by 2.89% to $3.7 million in 2025.
- Business Quant data shows Receivables - Other for TXMD at $3.7 million in Q3 2025, $3.7 million in Q2 2025, and $3.0 million in Q1 2025.